PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsAzithromycin
Azithromycin
Azasite, Azithromycin, Trovan/zithromax Compliance, Zithromax (azithromycin) is a small molecule pharmaceutical. Azithromycin was first approved as Zithromax on 1991-11-01. It is used to treat bacterial infections, chlamydia infections, haemophilus infections, infectious skin diseases, and mycoplasma pneumonia amongst others in the USA. It is known to target motilin receptor.
Download report
Favorite
COVID-19
Case Study: COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Azasite, Azithromycin, Zithromax (discontinued: Azithromycin, Zithromax, Zmax)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Azithromycin
Tradename
Company
Number
Date
Products
ZITHROMAXPfizerN-050693 RX1994-09-28
1 products, RLD, RS
ZITHROMAXPfizerN-050710 RX1995-10-19
2 products, RLD, RS
ZITHROMAXPfizerN-050711 RX1996-07-18
1 products, RLD
ZITHROMAXPfizerN-050733 RX1997-01-30
1 products, RLD, RS
ZITHROMAXPfizerN-050784 RX2002-05-24
1 products, RLD
AZASITEThea PharmaN-050810 RX2007-04-27
1 products, RLD, RS
Show 4 discontinued
Azithromycin dihydrate
+
Trovafloxacin mesylate
Tradename
Company
Number
Date
Products
TROVAN/ZITHROMAX COMPLIANCE PAKPfizerN-050762 DISCN1998-12-18
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
azasiteNew Drug Application2024-07-25
azithromycinANDA2025-01-13
azithromycin azithromycin dihydrateANDA2024-11-15
azithromycin dihydrateANDA2025-01-01
azithromycin monohydrateANDA2023-06-20
zithromaxNew Drug Application2024-11-27
zmaxNew Drug Application2011-01-26
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
nontuberculous mycobacterium infectionsEFO_0007461D009165A31.9
otitis mediaEFO_0004992D010033H66.9
bacterial infections—D001424A49
infectious skin diseases—D012874—
mycoplasma pneumoniaEFO_0007387D011019J15.7
chlamydia infectionsEFO_0007205D002690A74.9
streptococcal infectionsEFO_1001476D013290—
tonsillitisHP_0011110D014069J03
urethritisEFO_0003878D014526N34
staphylococcal infections—D013203A49.01
Show 11 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Azithromycin, Zmax, Pf Prism Cv
69844032024-02-14DPU-282
78878442024-02-14DP
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01F: Macrolides, lincosamides and streptogramins
— J01FA: Macrolides
— J01FA10: Azithromycin
— J01R: Combinations of antibacterials
— J01RA: Combinations of antibacterials
— J01RA07: Azithromycin, fluconazole and secnidazole
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA26: Azithromycin
HCPCS
Code
Description
J0456
Injection, azithromycin, 500 mg
Q0144
Azithromycin dihydrate, oral, capsules/powder, 1 gram
Clinical
No data
Drug
General
Drug common nameAzithromycin
INNazithromycin
Description
Azithromycin is a macrolide antibiotic useful for the treatment of bacterial infections. It has a role as an antibacterial drug, an environmental contaminant and a xenobiotic.
Classification
Small molecule
Drug classantibiotics (Streptomyces strains)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
Identifiers
PDB—
CAS-ID83905-01-5
RxCUI1299904
ChEMBL IDCHEMBL529
ChEBI ID2955
PubChem CID447043
DrugBankDB00207
UNII IDF94OW58Y8V (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Zithromax – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Azithromycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use